DNER and diffuse large B-cell lymphoma: To identify novel and potentially active combinations with BET inhibitors, the GCB DLBCL cell lines OCI‐LY‐19 and WSU‐DLCL2 were exposed to 348 compounds given as single agents (20 nM, 1 μM) and in combination with birabresib, at a concentration lower than the calculated IC50, (100 nM) (Figure 1; Table S1).